Related Experiment Video
Updated: Oct 19, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Pharmacist resource use across the United States: implications for teaching and practice
Rachel Whitney1, Hilary Jasmin2, Christopher Alan Giuliano3
1whitnera@musc.edu, Research & Education Informationist, MUSC Libraries, Medical University of South Carolina, Charleston, SC.
Objective:
To analyze practicing pharmacists' use of drug information (DI) resources in the United States.
Methods:
An electronic survey was distributed to practicing US pharmacists through professional organization email lists and social media. The survey questionnaire asked respondents which subscription-based DI resources are provided through their employer, whether they personally pay for additional resources, how often they use subscription-based resources, and other related questions.
Results:
The survey received 430 responses, 387 of which were able to be fully analyzed. The resources that respondents most frequently had access to through their employer were UpToDate (77.0%), Lexicomp (74.9%), and Micromedex (62.3%). Many respondents (40.8%) paid for subscriptions with personal funds, and 28.9% reported never experiencing access issues due to payment barriers. Respondents in community settings were more likely to have paid for resources with personal funds (57.1%, p<0.05) and have less access to resources (51.4%, p<0.05). In the open-text responses, the most desired resources were point-of-care tools (UpToDate) and DI databases (Lexicomp).
Conclusions:
US pharmacists experience a varied level of access to DI resources through their employer. Pharmacy educators should focus their instruction on resources that are the most accessible to practicing pharmacists. Many, especially community pharmacists, pay out of pocket for desired resources, presenting an opportunity to advocate for increased resources.
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Pharmacokinetics in Pediatric Patients: Drug Distribution
Dosage Regimens: Designs and Approaches
Dosage Regimens: Partial Pharmacokinetic Parameters
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Dosage Regimen: Individualization